JnJ live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

JnJ News

Sophia Claire 2025 Sep 04, 10:10

Apple iPhone 17 Price Speculation & New Devices: A Closer Look at Projections

Ava Grace 2025 Sep 04, 05:10

Goldman Sachs: Gold Could Hit $5,000 if Fed Credibility Falters

Ghko B 2025 Sep 03, 16:00

The Vanguard S&P 500 ETF Is Up: How Is VOO Stock Doing?

etfs stocks
Ghko B 2025 Sep 03, 16:00

Cardano price prediction: How high can Cardano (ADA) price go in 2025?

crypto
Frances Wang 2025 Sep 03, 16:00

PLTR stock is going down: What to know about Palantir Technologies?

stocks
Tommy Yap 2025 Jul 12, 21:00

 Week Ahead: Inflation Data from U.S., Canada, and U.K. Take Centre Stage

Forex Indices
Tommy Yap 2025 Apr 12, 16:00

Week Ahead: BoC and ECB Interest Rate Decisions in Focus This Week

Forex Indices
ECB set to cut rates for the third time this year
Neil Wilson 2024 Oct 10, 16:00

Week ahead: ECB set to cut as Wall Street earnings season gathers pace

Forex Indices
US earnings season kicks off, ECB expected to hold rates steady
Neil Wilson 2024 Jul 11, 21:00

Week ahead: US earnings season kicks off, ECB hold expected

Forex Indices
Oil steady, gold bearish trend
Neil Wilson 2024 Jan 22, 08:15

Europe Tries to Ride on US Coat-tails

Stocks Forex Commodities Indices

Latest news

Show more
Ava Grace 2025 Sep 04, 13:20

US Labor Market Concerns Grow as ADP Data Disappoints and Jobless Claims Rise

Liam James 2025 Sep 04, 13:20

Milan Fed Nomination Hearing: Central Bank Independence Under Scrutiny

Sophia Claire 2025 Sep 04, 09:20

Foreign Exchange Markets' Risk Aversion Spikes Ahead of US Jobs Data

Ava Grace 2025 Sep 04, 08:20

Unlikely Alliance Emerges in Congress to Ban Stock Trading for Lawmakers

Ava Grace 2025 Sep 04, 07:20

UK Gilts: A Generational Buying Opportunity? Analyzing the Bond Market Surge

Ava Grace 2025 Sep 04, 06:20

Optimus Next Gen: A Glimpse at Tesla's New Gold Robot and Musk's Future Vision

Sophia Claire 2025 Sep 04, 06:20

European Nations Weigh Ukraine Security Pledges Amid Deployment Disagreements

Sophia Claire 2025 Sep 04, 05:20

EU-US Trade Agreement Revamp Threatens Fragile Truce, Sparks Concerns

Info

Spread

1.12

Spread (%)

0.6297 %

Leverage

1:2

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Market open

Thursday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

428829016064

Shares Outstanding

2408339968

Earnings Date (Next)

2001-06-13

Div Yield

2025-09-09

Ex-Dividend Date

2025-08-26

Forward annual dividend rate

5.2

Forward annual dividend yield

0.0294

EPS

9.35

Learn more about this instrument

JnJ Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Frances Wang 2025 Sep 03, 16:00

Google shares jump: How to trade Alphabet (GOOG) stock CFDs?

Stocks
Frances Wang 2025 Sep 03, 16:00

What is iShares bitcoin Trust ETF IBIT: How to trade IBIT CFDs?

ETFs Crypto CFD Trading
Frances Wang 2025 Sep 03, 16:00

Crypto CFD Trading Brokers and Platforms: eToro, Plus500, BlackBull Markets

CFD Trading Crypto
Trustpilot